Gryphon Investors, a private equity firm, agreed to acquire Metagenics, a nutritional supplement company, from Alticor, an American conglomerate. Financial terms were not disclosed. "Metagenics has a unique position as a leader among nutrition brands recommended by healthcare practitioners across its three core geographic markets. We are excited to invest behind the Metagenics mission, including helping their healthcare practitioner partners to support the health of their patients around the world," Mike Ferry, Gryphon Operating Partner.